Protocol Ledger

NCT07675135 · Phase III · RECRUITING

A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy

Interventional Phase III clinical trial protocol NCT07675135 sponsored by Harmony Biosciences Management in Neurology, Psychiatry, and Pain, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2026-06-04 Enrollment: 258 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT07675135
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)258 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)2 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT07675135
Protocol FieldVerified Registry Value
NCT IdentifierNCT07675135
Consolidated Lead SponsorHarmony Biosciences Management
Therapeutic Condition CohortNeurology, Psychiatry, and Pain
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment258 participants (ESTIMATED)
Registered Start Date2026-06-04
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT07675135
Hospital Research SiteLocationSite Profile
Stanford Health Care and Stanford Cancer InstituteStanford, CAOpen Hospital Dossier ->
UCSF Medical Center and Helen Diller Cancer CenterSan Francisco, CAOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Neurology, Psychiatry, and Pain Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI